Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer

Surgery

Volumn 133, Issue 2, 2003, Pages 162-169

  Nakashima, Saburo ^a   Natsugoe, Shoji ^a   Matsumoto, Masataka ^a   Miyazono, Futoshi ^a   Nakajo, Akihiro ^a   Uchikura, Keiichiro ^a   Tokuda, Koki ^a   Ishigami, Sumiya ^a   Baba, Masamichi ^a   Takao, Sonshin ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MESSENGER RNA; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTERY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CELL MIGRATION; CHRONOLOGY; CIRCULATION; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; EVALUATION; FEMALE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SUPERIOR CAVA VEIN; TUMOR CELL; TUMOR RECURRENCE;

EID: 0037307521     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.9     Document Type: Article

References (29)

1. Natsugoe S, Shimazu H, Yoshinaka H, Baba M, Fukumoto T, Aikou T. Recurrence to thoracic esophageal cancer after three-field lymphadenectomy. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent advances in disease of the esophagus. Tokyo: Springer-Verlag; 1992. p. 795-9.
2. Romsdal MM, McGrath RG, Hoppe E, McGrew EA. Experimental model for the study of tumor cells in the blood. Acta Cytol 1965;9:141-5.
3. Liotta LA, Kleinerman J, Sadiel GM. Quantitative relationship of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
4. Tyzzer EE. Factors in the production and growth of tumor metastases. J Med Res 1913;28:309-31.
5. Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastases. J Surg Res 1990;49: 92-7.
6. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-20.
7. Kijima F, Natsugoe S, Takao S, Aridome K, Baba M, Yoshifumi M, et al. Detection and clinical significance of lymph node micrometatasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 2000;58:38-44.
8. Goldenberg DM, Sharkey RM, Primus FJ. Carcinoembryonic antigen in histology: immunoperoxidase staining of conventional tissue section. J Natl Cancer Inst 1976;57:11-22.
9. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-9.
10. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996;68:739-43.
11. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-34.
12. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, et al. Preoperative carcinoembryonic antigen level in colorectal cancer. N. Engl J Med 1978;299:448-51.
13. Wolmark N, Fisher B, Wieand HS, Henry RS, Lerner H, Legault-Poisson S, et al. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann Surg 1984;199:375-82.
14. Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M, et al. The prognostic value of serum and immunohistochemical tumor markers in advanced gastric cancer. Eur J Cancer 1996;32A:63-8.
15. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, et al. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 2001;32:41-4.
16. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-8.
17. Fuith LC, Daxenbichler G. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix. Gynecol Obstet Invest 1988;26:77-82.
18. Chou CY, Wang ST, Kuo HC, Tzeng CC, Yao BL. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer. Cancer 1994;74:2497-501.
19. Ikeda K. Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma. Nippon Geka Gakkai Zasshi 1991;92:387-96.
20. Sobin LH, Wittekind Ch, editors. International Union Against Cancer. TNM-classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997.
21. Miyazono F, Natsugoe S, Takao S, Tokuda K, Kijima F, Aridome K, et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001;233:189-94.
22. Noh YH, Kim G, Lim GR, Ro YT, Koo JH, Lee YS, et al. Detection of circulating tumor cells with gastrointestinal tract cancer using RT-PCR and its clinical implications. Exp Mol Med 2001;33:8-14.
23. Taniguchi T, Makino M, Suzuki K, Kaibara N. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 2000;89:970-6.
24. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Signifiant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 1999;232:58-65.
25. Mealy K, Feely J, Reid I, McSweeney J, Walsh T, Hennessy TP. Tumor marker detection in oesophageal carcinoma. Eur J Surg Oncol 1996;22:5050-7.
26. Kawaguchi H, Ohno S, Miyazaki M, Hashimoto K, Egashira A, Saeki H, et al. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrence. Cancer 2000;89:1413-7.
27. Gion M, Tremolada C, Mione R, della Palma P, Dittadi R, Zari C, et al. Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagus. Tumori 1989;31:489-93.
28. Clark GW, Ireland AP, Hagen JA, Collard JM, Peters JH, DeMeester TR. Carcinoembryonic antigen measurements in the management of esophageal cancer: an indicator of subclinical recurrence. Am J Surg 1995;170:579-600.
29. Tsuchiya Y, Onda M, Miyashita M, Sasajima K. Serum level of cytokeratin 19 fragment (CYFRA 21-1) indicates tumor stage and prognosis of squamous cell carcinoma of the esophagus. Med Oncol 1999;16:31-7.